Oncology Institute Inc (TOI) — Cash Flow Reinvestment Rate
Oncology Institute Inc (TOI) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $1.06 Million (capex $1.06 Million ) from operating cash flow of $3.23 Million. Explore Oncology Institute Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncology Institute Inc Cash Flow Reinvestment Rate (2018–2020)
Historical reinvestment intensity for Oncology Institute Inc across 3 annual periods. Also explore total assets of Oncology Institute Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oncology Institute Inc (2018–2020)
Year-by-year capital reinvestment analysis for Oncology Institute Inc. For live market cap and broader valuation context, see TOI stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 19.76x | $10.04 Million | $508.00K | $1.19 Million | ▲ +2865.3% |
| 2019 | 0.67x | $2.41 Million | $3.62 Million | $1.20 Million | ▲ +18.1% |
| 2018 | 0.56x | $3.18 Million | $5.64 Million | $695.96K | — |